Found: 94
Select item for more details and to access through your institution.
Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Immune checkpoint inhibitors for hepatocellular carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Molecular profiling and analysis of genetic aberrations aimed at identifying potential therapeutic targets in fibrolamellar carcinoma of the liver.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hepatocellular adenoma among adult survivors of childhood and young adult cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options.
- Published in:
- Journal of Surgical Oncology, 2016, v. 113, n. 1, p. 55, doi. 10.1002/jso.24086
- By:
- Publication type:
- Article
Skin necrosis induced by generic enoxaparin.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 4, p. 339, doi. 10.1002/ajh.23401
- By:
- Publication type:
- Article
MEK Inhibitor-Associated Ocular Hypertension.
- Published in:
- Ocular Oncology & Pathology, 2024, v. 10, n. 2, p. 98, doi. 10.1159/000535427
- By:
- Publication type:
- Article
A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603)
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603).
- Published in:
- Oncologist, 2010, v. 15, n. 12, p. 1310, doi. 10.1634/theoncologist.2010-0152
- By:
- Publication type:
- Article
Commentary: Sorafenib--The End of a Long Journey in Search of Systemic Therapy for Hepatocellular Carcinoma, or the Beginning?
- Published in:
- 2009
- By:
- Publication type:
- Editorial
Non-Surgical Locoregional Therapies Alone or in Combination with Systemic Therapy in Patients with Hepatocellular Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1748, doi. 10.3390/cancers15061748
- By:
- Publication type:
- Article
Sustained Complete Response after Biological Downstaging in Patients with Hepatocellular Carcinoma: XXL-Like Prioritization for Liver Transplantation or "Wait and See" Strategy?
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2406, doi. 10.3390/cancers13102406
- By:
- Publication type:
- Article
Estrogen Receptor-α Suppresses Liver Carcinogenesis and Establishes Sex-Specific Gene Expression.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2355, doi. 10.3390/cancers13102355
- By:
- Publication type:
- Article
The Hepatic Innovation Team Collaborative: A Successful Population-Based Approach to Hepatocellular Carcinoma Surveillance.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2251, doi. 10.3390/cancers13092251
- By:
- Publication type:
- Article
Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2134, doi. 10.3390/cancers13092134
- By:
- Publication type:
- Article
The Consumption of Cholesterol-Enriched Diets Conditions the Development of a Subtype of HCC with High Aggressiveness and Poor Prognosis.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1721, doi. 10.3390/cancers13071721
- By:
- Publication type:
- Article
Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1179, doi. 10.3390/cancers13051179
- By:
- Publication type:
- Article
SYSTEMIC THERAPIES FOR HEPATOCELLULAR CARCINOMA.
- Published in:
- Lebanese Medical Journal, 2010, v. 58, p. S28
- By:
- Publication type:
- Article
SYSTEMIC THERAPY AND NOVEL AGENTS IN THE TREATMENT OF PANCREAS CANCER.
- Published in:
- Lebanese Medical Journal, 2010, v. 58, p. S20
- By:
- Publication type:
- Article
TRIAGING AND CALL MANAGEMENT IN ONCOLOGY NURSING.
- Published in:
- Lebanese Medical Journal, 2010, v. 58, p. S66
- By:
- Publication type:
- Article
NURSING MANAGEMENT OF HAND-FOOT SYNDROME AND HAND-FOOT SKIN REACTION.
- Published in:
- Lebanese Medical Journal, 2010, v. 58, p. S63
- By:
- Publication type:
- Article
Identifying Vulnerable Older Adults with Cancer: Integrating Geriatric Assessment into Oncology Practice.
- Published in:
- Journal of the American Geriatrics Society, 2007, v. 55, n. 10, p. 1604, doi. 10.1111/j.1532-5415.2007.01367.x
- By:
- Publication type:
- Article
Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Postoperative outcomes following pancreaticoduodenectomy: how should age affect clinical practice?
- Published in:
- World Journal of Surgical Oncology, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1477-7819-11-131
- By:
- Publication type:
- Article
Lymph-node ratio is an independent prognostic factor in patients with stage III colorectal cancer: a retrospective study from the Middle East.
- Published in:
- World Journal of Surgical Oncology, 2012, v. 10, n. 1, p. 63, doi. 10.1186/1477-7819-10-63
- By:
- Publication type:
- Article
Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines.
- Published in:
- Oncologist, 2021, v. 26, n. 2, p. e316, doi. 10.1002/onco.13552
- By:
- Publication type:
- Article
Phase II Multicenter, Open‐Label Study of Oral ENMD‐2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1837, doi. 10.1634/theoncologist.2020-0093
- By:
- Publication type:
- Article
Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1825, doi. 10.1634/theoncologist.2020-0521
- By:
- Publication type:
- Article
A Multicenter Randomized Three‐Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 925, doi. 10.1634/theoncologist.2020-0367
- By:
- Publication type:
- Article
An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 747, doi. 10.1634/theoncologist.2018-0838
- By:
- Publication type:
- Article
A Phase Ib, Open‐Label Study of Dalantercept, an Activin Receptor‐Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 161, doi. 10.1634/theoncologist.2018-0654
- By:
- Publication type:
- Article
Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2017, v. 22, n. 7, p. 780, doi. 10.1634/theoncologist.2017-0058
- By:
- Publication type:
- Article
Systemic Therapy for Advanced Hepatocellular Carcinoma in an Evolving Landscape.
- Published in:
- Current Treatment Options in Oncology, 2019, v. 20, n. 1, p. 1, doi. 10.1007/s11864-019-0601-1
- By:
- Publication type:
- Article
Advanced Hepatocellular Cancer: the Current State of Future Research.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 9, p. 1995, doi. 10.1002/cncr.32740
- By:
- Publication type:
- Article
Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Treating advanced hepatocellular carcinoma: How to get out of first gear.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 20, p. 3122, doi. 10.1002/cncr.28850
- By:
- Publication type:
- Article
Neo‐adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 6, p. 735, doi. 10.1111/ajco.13775
- By:
- Publication type:
- Article
Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00371-2
- By:
- Publication type:
- Article
Proportion of cancer in a Middle eastern country attributable to established risk factors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Randomized Controlled Trial of a Cardiopulmonary Resuscitation Video in Advance Care Planning for Progressive Pancreas and Hepatobiliary Cancer Patients.
- Published in:
- Journal of Palliative Medicine, 2013, v. 16, n. 6, p. 623, doi. 10.1089/jpm.2012.0524
- By:
- Publication type:
- Article
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Reconciling the prospect of disease progression with goals and expectations: Development and validation of a measurement model in advanced cancer.
- Published in:
- Psycho-Oncology, 2022, v. 31, n. 6, p. 902, doi. 10.1002/pon.5878
- By:
- Publication type:
- Article
Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and Management.
- Published in:
- Annals of Global Health, 2023, v. 89, n. 1, p. 1, doi. 10.5334/aogh.3967
- By:
- Publication type:
- Article
ASO Visual Abstract: Has Management of Intrahepatic Cholangiocarcinoma Evolved with the Evidence? Trends and Practice Patterns from the National Cancer Database.
- Published in:
- 2024
- By:
- Publication type:
- Abstract